Role/Responsibilities of SIG Coordinator s5

ONCOLOGY NURSING SOCIETY

SIG COORDINATOR ANNUAL REPORT CHECKLIST

(Submit with Annual Report)

Enclosed is one copy of the completed Annual Reports due FEBRUARY 1, 2012.

Please check:

X Coordinator's Annual Report (due February 1)

SIG Minutes from Congress (previously submitted to C. DeMarco)

Sincerely,

Lynette C Woide, RN, MSN

Coordinator's Signature

Pharmaceutical/Industry Nursing

Name of SIG

Linda Person

SIG Council Representative

February 16, 2012

Date

PAGE 1 of 6

(Rev. 11/11)

ONCOLOGY NURSING SOCIETY

SIG COORDINATOR'S ANNUAL REPORT

Pharmaceutical/Industry Nursing SIG of the Oncology Nursing Society. Reporting Period: JAN 1, 2011 to DEC 31, 2011. Please list the leadership team (Work Group leaders/regional editors, etc.) and include their office or position. Due FEBRUARY 1, 2012.

PAGE 2 of 6

ONCOLOGY NURSING SOCIETY

SIG COORDINATOR'S ANNUAL REPORT

Pharmaceutical/Industry Nursing SIG of the Oncology Nursing Society. Covering the period from JAN 1, 2011 through DEC 31, 2011. Due FEBRUARY 1, 2012.

I. OVERVIEW OF THE PAST YEAR'S ACTIVITIES (as they relate to the purposes of SIGs): Please indicate number of purpose to which activity relates.

II. CURRENT SIG PROJECTS:

If funded indicate source of funding.

a. Completed since last annual report

b. Ongoing projects (please indicate estimated date of completion)

Continue efforts to submit and have accepted a topic at congress

PAGE 3 of 6

ONCOLOGY NURSING SOCIETY

SIG COORDINATOR'S ANNUAL REPORT

III. AWARDS:

IV. Leadership Succession Planning

This is critical to the future success of the SIG.

a.  Have you identified future leaders within your SIG? Yes X No

If so, who?

If not, what is your plan to ensure future SIG leaders? Continue to network; continued reaching out to membership

b.  What additional help from the Nominating Committee and/or staff do you require to help in this effort?

V. EDUCATIONAL ACTIVITIES AT CONGRESS, INSTITUTES OF LEARNING, ETC. for 2011:

VI. LEADERSHIP COMMUNICATION: (3 time per year)

VII. SIG PROJECT FUNDING MONIES/SEED MONEY/GRANTED THIS YEAR:

N/A

PAGE4 of 6

VIII. LIST WORK GROUPS AND CHAIRS FORMED/ONGOING SINCE LAST ANNUAL REPORT AND THEIR PURPOSES AND ACCOMPLISHMENTS:

The newsletter chair and I are trying desperately to find ways to get members involved. The pharmaceutical industry is in such a state of chaos right now, it is really difficult to get members to step up and become involved.

IX. LIST ANY RESEARCH PROJECTS THE SIG IS CURRENTLY INVOLVED WITH - INCLUDE BRIEF DESCRIPTION OF EACH PROJECT:

N/A

X. PUBLISHED PLANNING MEETING MINUTES (year from last Congress): X YES NO

PUBLISHED PLANNING MEETING AGENDA (year prior to last Congress): X YES NO

XI. LIST STRENGTHS OF SIG:

Strong newsletter chair.

Talented members

XII. LIST OPPORTUNITIES FOR IMPROVEMENT WITHIN SIG:

(State how you are addressing these.)

Trying to find ways to get members to step up for projects.

Continue to reach out to fellow SIGs for joint projects – presently in communication with Chemo SIG, no reply from Ambulatory/Office SIG

PAGE 5 of 6

XIII. SIG VIRTUAL COMMUNITY – LIST HOW YOU HAVE USED YOUR SITE

As we have no one to manage our vc, it really has gone un-updated and un used.

XIV. COLLABORATIONS (ONS, SIGS, ETC.):

We have reached out to the Breast Care SIG for collaboration. No reply.

I have recently reached out to the Chemotherapy and Ambulatory/Office Nursing SIGs. I am presently in communication with the Chemo SIG for potential collaboration at the 2012 Congress.

XV. ADDITIONAL: COMMENTS, QUESTIONS, PROBLEMS, AND SOLUTIONS:

Membership

(Rev. 11/11)

PAGE 6 of 6